Fallbericht
DOUBLE EFFECT OF PREGABALIN ON ANXIETY AND DYSLIPIDEMIA
PSYCHIATRIA DANUBINA · 2023
DOI: 10.24869/psyd.2023.448 ↗Kurz gefasst
Fallbericht in der Zeitschrift PSYCHIATRIA DANUBINA, 2023. Verfasst von Muhammed Emin Boylu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Council of Forensic Medicine, Expertise Department of Psychiatric Observation İstanbul, Turkey. Hauptthemen laut MEDLINE: Dyslipidemias, Anti-Anxiety Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
DyslipidemiasAnti-Anxiety AgentsHumansPregabalinAnxiety DisordersAnxietyDouble-Blind MethodTreatment Outcome
Substanzen
PregabalinAnti-Anxiety Agents
Autor:innen und Institutionen
- Council of Forensic Medicine, Expertise Department of Psychiatric Observation İstanbul, Turkey.
- Marmara University Medical Faculty Department of Psychiatry, İstanbul, Turkey.
- Bezmiâlem Foundation University Medical Faculty Department of Psychiatry, İstanbul, Turkey.
Zitieren
APA
Emin Boylu, M., Şahan, E., & Kırpınar, İ. (2023). DOUBLE EFFECT OF PREGABALIN ON ANXIETY AND DYSLIPIDEMIA. PSYCHIATRIA DANUBINA. https://doi.org/10.24869/psyd.2023.448
Vancouver
Emin Boylu M, Şahan E, Kırpınar İ. DOUBLE EFFECT OF PREGABALIN ON ANXIETY AND DYSLIPIDEMIA. PSYCHIATRIA DANUBINA. 2023. doi:10.24869/psyd.2023.448
BibTeX
@article{EminBoylu2023,
author = {Emin Boylu, Muhammed and Şahan, Ebru and Kırpınar, İsmet},
title = {DOUBLE EFFECT OF PREGABALIN ON ANXIETY AND DYSLIPIDEMIA},
journal = {PSYCHIATRIA DANUBINA},
year = {2023},
doi = {10.24869/psyd.2023.448}
}
EUVIMED